Christine Johnston

Summary

Affiliation: University of Washington
Country: USA

Publications

  1. ncbi Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials
    Christine Johnston
    Department of Medicine, University of Washington, Seattle, WA 98104, USA
    Lancet 379:641-7. 2012
  2. ncbi Herpes simplex virus type 2 serological testing and psychosocial harm: a systematic review
    Kaile Ross
    University of Washington Virology Research Clinic, Box 359928, 325 Ninth Avenue, Seattle, WA 98104, USA
    Sex Transm Infect 87:594-600. 2011
  3. ncbi HSV-2: in pursuit of a vaccine
    Christine Johnston
    Department of Medicine, University of Washington, Seattle, Washington, USA
    J Clin Invest 121:4600-9. 2011
  4. ncbi Herpes simplex virus viremia during primary genital infection
    Christine Johnston
    Department of Medicine, Universityof Washington, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    J Infect Dis 198:31-4. 2008
  5. ncbi Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in Uganda
    Christine Johnston
    Department of Medicine, University of Washington, Seattle, Washington, United States of America
    PLoS ONE 4:e4222. 2009
  6. ncbi Overlapping reactivations of herpes simplex virus type 2 in the genital and perianal mucosa
    Sunitha Tata
    Vaccine and Infectious Disease Institute, University of Washington, Seattle, USA
    J Infect Dis 201:499-504. 2010
  7. ncbi Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection
    Elizabeth Tronstein
    Department of Medicine, University of Washington, Seattle, USA
    JAMA 305:1441-9. 2011
  8. ncbi Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition
    Jia Zhu
    Vaccine and Infectious Disease Institute, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    Nat Med 15:886-92. 2009
  9. ncbi Diversity in CD8(+) T cell function and epitope breadth among persons with genital herpes
    Kerry J Laing
    Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    J Clin Immunol 30:703-22. 2010
  10. ncbi Clinician and patient recognition of anogenital herpes disease in HIV positive men who have sex with men
    Michael Isiah Sandlin
    School of Medicine, University of Washington, Seattle, WA 98104, USA
    Sex Transm Dis 38:833-6. 2011

Collaborators

Detail Information

Publications10

  1. ncbi Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials
    Christine Johnston
    Department of Medicine, University of Washington, Seattle, WA 98104, USA
    Lancet 379:641-7. 2012
    ..Skin and mucosal herpes simplex virus type 2 (HSV-2) shedding predominantly occurs in short subclinical episodes. We assessed whether standard-dose or high-dose antiviral therapy reduces the frequency of such shedding...
  2. ncbi Herpes simplex virus type 2 serological testing and psychosocial harm: a systematic review
    Kaile Ross
    University of Washington Virology Research Clinic, Box 359928, 325 Ninth Avenue, Seattle, WA 98104, USA
    Sex Transm Infect 87:594-600. 2011
    ..Concerns about sustained emotional impact should not deter clinicians from offering HSV-2 serological testing to appropriate patients...
  3. ncbi HSV-2: in pursuit of a vaccine
    Christine Johnston
    Department of Medicine, University of Washington, Seattle, Washington, USA
    J Clin Invest 121:4600-9. 2011
    ....
  4. ncbi Herpes simplex virus viremia during primary genital infection
    Christine Johnston
    Department of Medicine, Universityof Washington, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    J Infect Dis 198:31-4. 2008
    ..61%; P=.01). Viremia was detected more frequently and at a higher number of copies per milliliter early in infection. We conclude that HSV viremia during primary genital HSV infection is common, especially among women...
  5. ncbi Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in Uganda
    Christine Johnston
    Department of Medicine, University of Washington, Seattle, Washington, United States of America
    PLoS ONE 4:e4222. 2009
    ..Human herpesvirus-8 (HHV-8) replication is important both in transmission of HHV-8 and progression to KS. We characterized the sites and frequency of HHV-8 detection in Ugandans with and without HIV and KS...
  6. ncbi Overlapping reactivations of herpes simplex virus type 2 in the genital and perianal mucosa
    Sunitha Tata
    Vaccine and Infectious Disease Institute, University of Washington, Seattle, USA
    J Infect Dis 201:499-504. 2010
    ..Genital shedding of herpes simplex virus (HSV) type 2 occurs frequently. Anatomic patterns of genital HSV-2 reactivation have not been intensively studied...
  7. ncbi Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection
    Elizabeth Tronstein
    Department of Medicine, University of Washington, Seattle, USA
    JAMA 305:1441-9. 2011
    ..The course of natural history of HSV-2 in asymptomatic, seropositive persons is uncertain...
  8. ncbi Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition
    Jia Zhu
    Vaccine and Infectious Disease Institute, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    Nat Med 15:886-92. 2009
    ..The persistence and enrichment of HIV receptor-positive inflammatory cells in the genitalia help explain the inability of anti-HSV-2 therapy to reduce HIV acquisition...
  9. ncbi Diversity in CD8(+) T cell function and epitope breadth among persons with genital herpes
    Kerry J Laing
    Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    J Clin Immunol 30:703-22. 2010
    ..The diversity in T cell response in these ex vivo assessments offers the potential of defining immune correlates of HSV-2 reactivation in humans...
  10. ncbi Clinician and patient recognition of anogenital herpes disease in HIV positive men who have sex with men
    Michael Isiah Sandlin
    School of Medicine, University of Washington, Seattle, WA 98104, USA
    Sex Transm Dis 38:833-6. 2011
    ..When compared with clinician examination, HIV/HSV-2 coinfected men who have sex with men are frequently unaware of anogenital ulcers. These data highlight the importance of condom use and the need for new HSV-2 prevention strategies...